The UK government plans to give the AI Biosecurity Lab (AIBL) £100 million in public funding to pursue earlier detection of biological threats and faster development of medical countermeasures. In a plan published October 24, 2026, the Cabinet Office also described separate support from OpenAI and Anthropic, while HM Treasury put the wider National AI Biosecurity Initiative at £165 million in government funding.
What the lab plans to do
AIBL’s first priorities are to detect emerging biological threats earlier and accelerate the development of vaccines, treatments and other medical countermeasures. The UK government plans for the lab to operate as an independent nonprofit, with a scientific advisory committee drawing on academia, industry and the third sector.
The committee’s membership and the lab’s detailed research program were not part of the published plan. The announced priorities, though, put threat detection and medical preparedness at the center of the initiative.
How the funding and company support differ
The £100 million for AIBL and a separate £65 million for biological surveillance and medical countermeasures for priority pathogens make up the government’s £165 million National AI Biosecurity Initiative. OpenAI’s and Anthropic’s commitments take different forms, including compute and model credits, model access and technical support.
| Contributor | Amount | Form and purpose |
| UK government | £100 million | Public funding for AIBL |
| UK government | £65 million | Separate funding for biological surveillance and medical countermeasures for priority pathogens |
| OpenAI | £100 million | Compute and model credits, plus trusted access to relevant models through its Rosalind Biodefense program |
| Anthropic | Up to £100 million | Model credits, trusted model access and dedicated technical support |
OpenAI and Anthropic’s announced support is valued at up to £200 million combined. That figure describes company commitments in credits, access and technical services, alongside the government’s separate funding allocations.
The UK has also attracted other AI safety commitments. NeoTeo previously covered Nvidia’s five-year, $250 million computing pledge for UK AI safety and security research, a separate initiative from AIBL.
Research and public-sector partners
Google DeepMind is a research partner: its scientists and biosecurity experts are expected to collaborate, and the company will look to provide trusted access to frontier Gemini and specialized science models. Basecamp Research is to provide access to AI-biology models, capabilities and technical expertise.
The government also named the UK Health Security Agency (UKHSA), the Animal and Plant Health Agency (APHA) and the Defence Science and Technology Laboratory (Dstl) among the initiative’s partners. The Medicines and Healthcare products Regulatory Agency (MHRA) is to work with AIBL on health-emergency preparation and the regulation of AI-designed medicines. Academic institutions are included among the intended partners.
